- Investing Ideas
- Spanish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Spanish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
2
0 new
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Grifols
Market Cap: €5.8b
Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
GRF
€9.66
7D
2.5%
1Y
-22.4%
Oryzon Genomics
Market Cap: €242.4m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.96
7D
4.2%
1Y
8.8%